Pralhada Rao Raghavendra, Vaidyanathan Nanditha, Rengasamy Mathiyazhagan, Mammen Oommen Anup, Somaiya Neeti, Jagannath M R
Biology Group, Connexios Life Sciences Private Limited, No.49 Shilpa Vidya, First Main Road, 3rd Phase JP Nagara, Bangalore 560078, India.
J Lipids. 2013;2013:178910. doi: 10.1155/2013/178910. Epub 2013 Aug 4.
Sphingolipids, a family of membrane lipids, are bioactive molecules that participate in diverse functions controlling fundamental cellular processes such as cell division, differentiation, and cell death. Given that most of these cellular processes form the basis for several pathologies, it is not surprising that sphingolipids are key players in several pathological processes. This review discusses the role of the sphingolipid metabolic pathway in diabetes, Alzheimer's disease, and hepatocellular carcinoma, with a special emphasis on the changes in gene expression pattern in these disease conditions. For convenience, the sphingolipid metabolic pathway is divided into hypothetical compartments (modules) with each compartment representing a physiological process and changes in gene expression pattern are mapped to each of these modules. It appears that alterations in the gene expression pattern in these disease conditions are biased to manipulate the system in order to result in a particular disease.
鞘脂是一类膜脂,属于生物活性分子,参与多种控制基本细胞过程的功能,如细胞分裂、分化和细胞死亡。鉴于这些细胞过程大多构成了多种病理状况的基础,鞘脂成为多种病理过程的关键参与者也就不足为奇了。本综述讨论了鞘脂代谢途径在糖尿病、阿尔茨海默病和肝细胞癌中的作用,特别强调了这些疾病状态下基因表达模式的变化。为方便起见,鞘脂代谢途径被划分为假设的区室(模块),每个区室代表一个生理过程,基因表达模式的变化则映射到每个模块。在这些疾病状态下,基因表达模式的改变似乎倾向于操纵系统以导致特定疾病。